These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 26305617)

  • 1. Effects of TZD Use and Discontinuation on Fracture Rates in ACCORD Bone Study.
    Schwartz AV; Chen H; Ambrosius WT; Sood A; Josse RG; Bonds DE; Schnall AM; Vittinghoff E; Bauer DC; Banerji MA; Cohen RM; Hamilton BP; Isakova T; Sellmeyer DE; Simmons DL; Shibli-Rahhal A; Williamson JD; Margolis KL
    J Clin Endocrinol Metab; 2015 Nov; 100(11):4059-66. PubMed ID: 26305617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of stroke with thiazolidinediones: a ten-year nationwide population-based cohort study.
    Lu CJ; Sun Y; Muo CH; Chen RC; Chen PC; Hsu CY
    Cerebrovasc Dis; 2013; 36(2):145-51. PubMed ID: 24029780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The thiazolidinediones rosiglitazone and pioglitazone and the risk of coronary heart disease: a retrospective cohort study using a US health insurance database.
    Ziyadeh N; McAfee AT; Koro C; Landon J; Arnold Chan K
    Clin Ther; 2009 Nov; 31(11):2665-77. PubMed ID: 20110009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between longer therapy with thiazolidinediones and risk of bladder cancer: a cohort study.
    Mamtani R; Haynes K; Bilker WB; Vaughn DJ; Strom BL; Glanz K; Lewis JD
    J Natl Cancer Inst; 2012 Sep; 104(18):1411-21. PubMed ID: 22878886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiazolidinediones and fractures: evidence from translating research into action for diabetes.
    Bilik D; McEwen LN; Brown MB; Pomeroy NE; Kim C; Asao K; Crosson JC; Duru OK; Ferrara A; Hsiao VC; Karter AJ; Lee PG; Marrero DG; Selby JV; Subramanian U; Herman WH
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4560-5. PubMed ID: 20631021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of cardiovascular events in which 2 thiazolidinediones are used as add-on treatments for type 2 diabetes mellitus in a Taiwanese population.
    Wang CC; Chen WL; Kao TW; Chang YW; Loh CH; Chou CC
    Clin Ther; 2011 Dec; 33(12):1904-13. PubMed ID: 22118894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization and costs for compliant patients initiating therapy with pioglitazone or rosiglitazone versus insulin in a Medicaid fee-for-service population.
    Kalsekar I; Iyer S; Mody R; Rajagopalan R; Kavookjian J
    J Manag Care Pharm; 2006 Mar; 12(2):121-9. PubMed ID: 16515370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosiglitazone and pioglitazone increase fracture risk in women and men with type 2 diabetes.
    Aubert RE; Herrera V; Chen W; Haffner SM; Pendergrass M
    Diabetes Obes Metab; 2010 Aug; 12(8):716-21. PubMed ID: 20590749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidiabetic prescribing trends and predictors of thiazolidinedione discontinuation following the 2007 rosiglitazone safety alert.
    Hurren KM; Taylor TN; Jaber LA
    Diabetes Res Clin Pract; 2011 Jul; 93(1):49-55. PubMed ID: 21440324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiazolidinedione use and the longitudinal risk of fractures in patients with type 2 diabetes mellitus.
    Habib ZA; Havstad SL; Wells K; Divine G; Pladevall M; Williams LK
    J Clin Endocrinol Metab; 2010 Feb; 95(2):592-600. PubMed ID: 20061432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs.
    Colhoun HM; Livingstone SJ; Looker HC; Morris AD; Wild SH; Lindsay RS; Reed C; Donnan PT; Guthrie B; Leese GP; McKnight J; Pearson DW; Pearson E; Petrie JR; Philip S; Sattar N; Sullivan FM; McKeigue P;
    Diabetologia; 2012 Nov; 55(11):2929-37. PubMed ID: 22945303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk of fractures associated with thiazolidinediones: a self-controlled case-series study.
    Douglas IJ; Evans SJ; Pocock S; Smeeth L
    PLoS Med; 2009 Sep; 6(9):e1000154. PubMed ID: 19787025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiazolidinediones, cardiovascular disease and cardiovascular mortality: translating research into action for diabetes (TRIAD).
    Bilik D; McEwen LN; Brown MB; Selby JV; Karter AJ; Marrero DG; Hsiao VC; Tseng CW; Mangione CM; Lasser NL; Crosson JC; Herman WH
    Pharmacoepidemiol Drug Saf; 2010 Jul; 19(7):715-21. PubMed ID: 20583206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosiglitazone and pioglitazone utilization from January 2007 through May 2008 associated with five risk-warning events.
    Starner CI; Schafer JA; Heaton AH; Gleason PP
    J Manag Care Pharm; 2008; 14(6):523-31. PubMed ID: 18693776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cohort study of thiazolidinediones and fractures in older adults with diabetes.
    Solomon DH; Cadarette SM; Choudhry NK; Canning C; Levin R; Stürmer T
    J Clin Endocrinol Metab; 2009 Aug; 94(8):2792-8. PubMed ID: 19470635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thiazolidinedione use and bone loss in older diabetic adults.
    Schwartz AV; Sellmeyer DE; Vittinghoff E; Palermo L; Lecka-Czernik B; Feingold KR; Strotmeyer ES; Resnick HE; Carbone L; Beamer BA; Park SW; Lane NE; Harris TB; Cummings SR
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3349-54. PubMed ID: 16608888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis.
    Loke YK; Singh S; Furberg CD
    CMAJ; 2009 Jan; 180(1):32-9. PubMed ID: 19073651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of fracture with thiazolidinediones: an updated meta-analysis of randomized clinical trials.
    Zhu ZN; Jiang YF; Ding T
    Bone; 2014 Nov; 68():115-23. PubMed ID: 25173606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of fracture with thiazolidinediones: disease or drugs?
    Bazelier MT; Vestergaard P; Gallagher AM; van Staa TP; Cooper C; Leufkens HG; de Vries F
    Calcif Tissue Int; 2012 Jun; 90(6):450-7. PubMed ID: 22488176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thiazolidinediones and fractures in men and women.
    Dormuth CR; Carney G; Carleton B; Bassett K; Wright JM
    Arch Intern Med; 2009 Aug; 169(15):1395-402. PubMed ID: 19667303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.